Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases.
Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases.
复制标题
DOI：
10.1016/s2665-9913(21)00039-4
复制
发表时间：
2021-04
期刊：
影响因子：
--
通讯作者：
Arnaud L
中科院分区：
文献类型：
--
作者：
Felten R;Dubois M;Ugarte-Gil MF;Chaudier A;Kawka L;Bergier H;Costecalde C;Pijnenburg L;Fort J;Chatelus E;Sordet C;Javier RM;Gottenberg JE;Sibilia J;Fuentes-Silva Y;Arnaud L
接种疫苗是预防普通人群以及自身免疫性和炎症性风湿病患者感染的重要和有效的工具。尽管制定了具体的指导方针，但在这一目标人群中，流感和肺炎球菌疫苗接种率没有达到推荐水平，这一点已经得到了充分的证实。1、2疫苗接种率与对疫苗知识的缺乏和对疫苗接种的总体态度呈负相关。2我们做了一项国际研究(新冠肺炎疫苗接种)，以探索患者和卫生保健专业人员对新冠肺炎疫苗接种的感受。我们的主要目标是描述系统性自身免疫性或炎症性风湿病患者和医疗保健专业人员对新冠肺炎疫苗接种的期望和潜在担忧。该研究包括57个基于网络的问题，涉及流行病学、社会人口学和流行病学因素，与对新冠肺炎疫苗接种的期望和潜在担忧相关。这项研究的目标是自我报告患有系统性自身免疫性或炎症性风湿病的患者和医疗保健专业人员。卫生保健专业人员为对照组，没有系统性自身免疫性或炎症性风湿病。在2020年12月12日至12月21日期间，通过患者协会和各种医学会(不仅限于风湿病医生)通过社交媒体和邮件确保了研究的分歧性。这项研究得到了
Vaccination is an important and effective tool to prevent infections in the general population, as well as in patients with autoimmune and inflammatory rheumatic diseases. It has been well established that influenza and pneumococcal vaccination rates do not reach recommended levels in this target population, despite specific guidelines. 1, 2 Vaccine uptake has been negatively associated with low knowledge of vaccines and unfavorable attitudes towards vaccination in general. 2 We did an international study (VAccinations against COVid-19 [VAXICOV]) to explore the feelings of patients and health-care professionals regarding COVID-19 vaccination. Our main objective was to describe the expectations and potential concerns related to COVID-19 vaccination of patients with systemic autoimmune or inflammatory rheumatic diseases and health-care professionals.The study consisted of 57 web-based questions that addressed epidemiological, socio-demographic, and thera peutic elements associated with expectations and potential concerns regarding COVID-19 vaccination. The study targeted patients with a self-reported diagnosis of systemic autoimmune or inflammatory rheumatic diseases and health-care professionals. Health-care professionals were the control group and had no systemic autoimmune or inflammatory rheumatic diseases. Dissemin ation of the study was ensured through social media and mailings via patient associations and various medical societies (not only limited to rheumatologists) between Dec 12 and Dec 21, 2020. The study was approved by